Cytokine receptor signal transduction through Jak tyrosine kinases and Stat transcription factors

APMIS

Volumn 105, Issue 7, 1997, Pages 497-509

  Silvennoinen, Olli ^a   Saharinen, Pipsa ^b   Paukku, Kirsi ^b   Takaluoma, Kati ^b   Kovanen, Panu ^b  

^a UNIVERSITY OF TAMPERE   (Finland)

^b NONE

Author keywords

Cytokine; Jak tyrosine kinase; Signal transduction; Stat transcription factor

Indexed keywords

CYTOKINE RECEPTOR; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030862714     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb05047.x     Document Type: Review

References (67)

1. Akira, S., Taga, T. & Kishimoto, T.: Interleukin-6 in biology and medicine. Adv. Immunol. 54: 1-78, 1993.
2. Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., Wei, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M. & Kishimoto, T.: Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77: 63-71, 1994.
3. Arai, A.-I., Lee, F., Miyajima, A., Miyatake, S., Arai, N. & Yokota, T.: Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59: 783-836, 1990.
4. Azam, M., Erdjument-Bromage, H., Kreider, B., Xia, M., Quelle, F., Basu, R., Saris, C., Tempst, P., Ihle, J. N. & Schindler, C.: Interleukin-3 signals through multiple isoforms of Stat5. EMBO J. 14: 1402-1411, 1995.
5. Bazan, J. F.: Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. 87: 6934-6938, 1990.
6. Binari, R. & Perrimon, N.: Stripe-specific regulation of pair-rule genes by hopscotch, a putative Jak family tyrosine kinase in Drosophila. Genes Dev. 8: 300-312, 1994.
7. Bluyssen, H. A. R., Muzaffar, R., Vliestustra, R. J., van der Made, A. C. J., Leung, S., Stark, G. R., Kerr, I. M., Trapman, J. & Levy, D. E.: Combinatorial association and abundance of interferon gene factor 3 components dictate the selectivity of interferon responses. Proc. Natl. Acad. Sci. 92: 5645-5649, 1995.
8. WAF1/CPI1 mediated by STAT1. Science 272: 719-722, 1996.
9. Corey, S. J., Burkhardt, A. L., Bolen, J. B., Geahlen, R. L., Tkatch, L. S. & Tweardy, D. J.: Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc. Natl. Acad. Sci. 91: 4683-4687, 1994.
10. D'Andrea, A. D., Lodish, H. F. & Wong, G. G.: Expression cloning of the murine erythropoietin receptor. Cell 57: 277-285, 1989.
11. Durbin, J. E., Hackenmiller, R., Simon, M. S. & Levy, D. E.: Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450, 1996.
12. Firmbach-Kraft, I., Byers, M., Shows, T., Dalla-Favera, R. & Krolewsky, J. J.: tyk2, prototype of a novel class of non-receptor tyrosine kinases. Oncogene 5: 1329-1336, 1990.
13. Gupta, S., Yan, H., Wong, L. H., Ralph, S., Krolewsky, J. & Schindler, C.: The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-α signals. EMBO J. 15: 1075-1084, 1996.
14. Guschin, D., Rogers, N., Briscoe, J., Witthuhn, B., Watling, D., Horn, F., Pellegrini, S., Yasukawa, K., Heinrich, P., Stark, G. R., Ihle, J. N. & Kerr, I. M.: A major role for the protein tyrosine kinase Jak1 in the Jak/STAT signal transduction pathway in response to interleukin-6. EMBO J. 14: 1421-1429, 1995.
15. He, T.-C., Jiang, N., Zhuang, H., Quelle, D. E. & Wojchowski, D. M.: The extended Box2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells. J. Biol. Chem. 269: 18291-18294, 1994.
16. Heim, M. H., Kerr, I. M., Stark, G. R. & Darnell, J. E.: Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 267: 1347-1349, 1995.
17. Horvath, C. M., Wen, Z. & Darnell, J. E.: A Stat protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9: 984-994, 1995.
18. Hou, J., Schindler, U., Henzel, W. J., Ho, T. C., Brasser, M. & McKnight, S. L.: An interleukin-4-induced transcription factor: IL-4 Stat. Science 265: 1701-1706, 1994.
19. Hou, X. S., Melnick, M. B. & Perrimon, N.: marelle acts downstream of HOP/JAK kinase and encodes a protein similar to the mammalian STATs. Cell 84: 411-419, 1996.
20. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K. & Silvennoinen, O.: Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13: 369-398, 1995.
21. Ihle, J. N.: Cytokine receptor signalling. Nature 377: 591-594, 1995.
22. Ihle, J. N.: STATs: Signal transducers and activators of transcription. Cell 84: 331-334, 1996.
23. Kawahara, A., Minami, Y., Miyazaki, T., Ihle, J. N. & Taniguchi, T.: Critical role of the interleukin 2 receptor (IL-2) receptor γ-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl. Acad. Sci. 92: 8724-8728, 1995.
24. Kondo, M., Takeshita, T., Ishii, N., Nakamura, M., Sudo, T., Nishikawa, S. & Sugamura, K.: Sharing of the interleukin-2 receptor γ chain between receptors for IL-2 and IL-4. Science 262: 1874-1876, 1993.
25. Kotenko, S. V., Izotova, L. S., Pollack, B. P., Muthukumaran, G., Paukku, K., Silvennoinen, O., Ihle, J. N. & Pestka, S.: Other kinases can substitute for Jak2 in signal transduction by interferon-γ. J. Biol. Chem. 271: 17174-17182, 1996.
26. Leaman, D. W., Pisharody, S., Flickinger, T. W., Commane, M. A., Schlessinger, J., Kerr, I. M., Levy, D. E. & Stark, G. R.: Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol. Cell. Biol. 16: 369-375, 1996.
27. Tum-1 Jak kinase causes leukemia-like hematopoietic defects. EMBO J. 14: 1412-1420, 1995.
28. Kinoshita, T., Yokota, T., Arai, K. & Miyajima, A.: Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J. 14: 266-275, 1995.
29. Macchi, P., Villa, A., Giliani, S., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A.G., Johnston, J. A., Candotti, F., O'Shea, J. J., Vezzoni, P. & Notarangelo, L. D.: Mutations of Jak3-gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377: 65-68, 1995.
30. Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M. & Schreiber, R. D.: Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442, 1996.
31. Miura, O., DaAndrea, A., Kabat, D. & Ihle, J. N.: Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol. Cell. Biol. 11: 4895-4902, 1991.
32. Miyajima, A., Mui, A. L.-F., Ogorochi, T. & Sakamaki, K.: Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82: 1960-1974, 1993.
33. Miyazaki, T., Kawahara, A., Fujii, H., Nakagawa, Y., Minami, Y., Liu, Z.-J., Oishi, I., Silvennoinen, O., Witthuhn, B., Ihle, J. N. & Taniguchi, T.: Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266: 1045-1047, 1994.
34. Miyazaki, T., Liu, Z.-J., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E. L., Perlmutter, R. M. & Taniguchi, T.: Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81: 223-231, 1995.
35. Moriggl, R., Gouilleux-Gruart, V., Jähne, R., Bechtold, S., Gartmann, C., Liu, X., Hennighausen, L., Sotiropoulos, A., Groner, B. & Gouilleux, F.: Deletion of the carboxyl-terminal transactivation domain of MGF-STAT5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell. Biol. 16: 5691-5700, 1996.
36. Muller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A., Barbieri, A., Witthuhn, B., Schindler, C., Pellegrini, S., Wilks, A., Ihle, J. N., Stark, G. R. & Kerr, I. M.: The protein tyrosine kinase Jak1 complements defects in interferon-α/β and -γ signal transduction. Nature 366: 129-135, 1993.
37. Murakami, M., Narazaki, M., Hibi, M., Yawata, H., Yasakawa, K., Hamaguchi, M., Taga, T. & Kishimoto, T.: Critical cytoplasmic region of the interleukin 6 signal transducer is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. 88: 11349-11353, 1991.
38. Nakamura, Y., Russell, S. M., Mess, S. A., Friedman, M., Erdos, M., Francois, C., Jacques, Y., Adelson, S. & Leonard, W. J.: Heterodimerization of the IL-2 receptor β- and γ-chain is required for signaling. Nature 369: 330-333, 1994.
39. Neidhart, J. A.: Hematopoietic cytokines. Current use in cancer therapy. Cancer (Suppl.) 72: 3381-3386, 1993.
40. Nosaka, T., van Deursen, J. M. A., Tripp, R. A., Thierfelder, W. E., Witthuhn, B. A., McMickle, A. P., Doherty, P. C., Grosveld, G. C. & Ihle, J. N.: Defective lymphoid development in mice lacking Jak3. Science 270: 800-802, 1995.
41. Quelle, F. W., Wang, D., Nosaka, T., Thierfelder, W. E., Stravopodis, D., Weinstein, Y. & Ihle, J. N.: Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16: 1622-1631, 1996.
42. c chains with Jak1 and Jak3: Implications for XSCID and SCID. Science 266: 1042-1045, 1994.
43. Schindler, C., Shuai, K., Prezioso, V. R. & Darnell, J. E.: Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257: 809-813, 1992.
44. Schindler, C. & Darnell, J. E.: Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu. Rev. Biochem. 64: 621-651, 1995.
45. Shimoda, K., van Deursen, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignalli, D. A. A., Doherty, P. C., Grosveld, G., Paul, W. E. & Ihle, J. N.: Disruption of the murine Stat6 gene blocks IL-4-induced Th2 development and IgE switching. Nature 380: 630-633, 1996.
46. Shuai, K., Horvath, C. M., Huang, L. H. T., Qureshi, S. A., Cowburn, D. & Darnell, J. E.: Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76: 821-828, 1994.
47. Shuai, K., Liao, J. & Song, M. M.: Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol. Cell. Biol. 16: 4932-4941, 1996.
48. Silvennoinen, O., Witthuhn, B., Quelle, F. W., Cleveland, J., Yi, T. & Ihle, J. N.: Structure of the murine Jak2 protein tyrosine kinase and its role in IL-3 signal transduction. Proc. Natl. Acad. Sci. 90: 8429-8433, 1993.
49. Silvennoinen, O., Schindler, C., Schlessinger, J. & Levy, D. E.: Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science 261: 1736-1739, 1993.
50. Silvennoinen, O., Ihle, J. N., Schlessinger, J. & Levy, D. E.: Interferon-induced nuclear signaling by Jak protein tyrosine kinases. Nature 366: 583-585, 1993.
51. Silvennoinen, O. & Ihle, J. N.: Signaling by the hematopoietic cytokine receptors. R.G. Landes, Springer Verlag, Austin, TX, pp. 1-229.
52. Stahl, N., Boulton, T. G., Farrugella, T., Ip, N., Davis, S., Witthuhn, B., Quelle, F., Silvennoinen, O., Barbieri, G., Pellegrini, S., Ihle, J. N. & Yancopoulos, G.: Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263: 92-95, 1994.
53. Taniguchi, T.: Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268: 251-255, 1995.
54. Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignalli, D. A. A., Doherty, P. C., Grosveld, G. C. & Ihle, J. N.: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382: 171-174, 1996.
55. Vinkemeier, U., Cohen, S. L., Moarefi, I., Chait, B. T., Kuriyan, J. & Darnell, J. E.: DNA binding of in vitro activated Stat1a, Stat1b and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 15: 5616-5626, 1996.
56. Velazquez, L., Fellous, M., Stark, G. R. & Pellegrini, S.: A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70: 313-322, 1992.
57. Velazquez, L., Mogensen, K. E., Barbieri, G., Fellous, M., Uze, G. & Pellegrini, S.: Distinct domains of the protein tyrosine kinase tyk2 required for binding of the interferon-α/β and for signal transduction. J. Biol. Chem. 270: 3327-3334, 1995.
58. Wakao, H., Gouilleux, F. & Groner, B.: Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor-gene family and confers the prolactin response. EMBO J. 13: 2182-2191, 1994.
59. Wang, L.-M., Myers, M. G., Sun, X.-J., Aaronson, S. A., White, M. & Pierce, J. H.: IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science 261: 1591-1594, 1993.
60. Watling, D., Guschin, D., Muller, M., Silvennoinen, O., Witthuhn, B., Quelle, F., Rogers, N., Schindler, C., Stark, G., Ihle, J.N. & Kerr, I.: Complementation by the tyrosine kinase JAK.2 of a mutant cell line defective in the interferon-γ signal transduction. Nature 566: 166-170, 1993.
61. Wen, Z., Zhong, Z. & Darnell, J. E.: Maximal activation of transcription requires both tyrosine and serine phosphorylation. Cell 82: 241-250, 1995.
62. Wilks, A. F., Harpur, A. G., Kurdan, R. R., Ralph, S. J., Zurcher, G. & Ziemicki, A.: Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol. Cell. Biol. 11: 2057-2065, 1991.
63. Winston, L. A. & Hunter, T.: Jak2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J. Biol. Chem. 270: 30837-30840, 1995.
64. Witthuhn, B., Quelle, F. W., Silvennoinen, O., Yi, T., Tang, B., Miura, O. & Ihle, J. N.: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following EPO stimulation. Cell 74: 227-236, 1993.
65. Witthuhn, B. A., Silvennoinen, O., Miura, O., Lai, K. S., Cwik, C., Liu, E. T. & Ihle, J. N.: Involvement of the Jak-3 Janus kinase in signaling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370: 153-157, 1994.
66. Yamamoto, K., Quelle, F. W., Thierfelder, W. E., Kreider, B. L., Gilbert, D. J., Jenkins, N. A., Copeland, N. G., Silvennoinen, O. & Ihle, J. N.: Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol. Cell. Biol. 14: 4342-4349, 1994.
67. Yamanaka, Y., Nakajima, K., Fukuda, T., Hibi, M. & Hirano, T.: Differentiation and growth arrest signals through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J. 15: 1557-1565, 1996.